Similarly, ApoE, activated in Oprm1 positive cells in the striatum during morphine withdrawal, has been implicated in several neuropsychiatric disorders including depression and schizophrenia [28], which can be co-morbid with substance use disorder [34]. Here, APOE is linked to depressive symptom measurement.